Has Audrey Nath, MD received payments from drug or device companies?

Yes. Drug and device makers reported $404,416 in general payments to Audrey Nath, MD across 36 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Audrey Nath, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Audrey Nath, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Audrey Nath, MD

Neurological Surgery · Galveston, TXNPI 1053679019

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $403,740 of the $404,416 with a category attached, or 99.8%. Ceribell, Inc. accounts for 99.8% of it on its own, with 2 other manufacturers making up the rest. Among neurological surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$404,416in general payments, 2019–2025

Across 36 payments — averaging $11,234 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Ceribell, Inc.$404K
SK Life Science, Inc.$629
Jazz Pharmaceuticals Inc.$47

What the payments were for

Consulting fees$403,740100%
Food & beverage$6760%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Ceribell, Inc.	24	$403,740
SK Life Science, Inc.	11	$629
Jazz Pharmaceuticals Inc.	1	$47

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$404,416 in reported general payments places this provider in the 95th percentile of 582 neurological surgery providers in Texas.

See all neurological surgery providers in Texas →

Medicare billing

Part B allowed, 2024

$84,043

Medicare patients

410

Services billed

1,347

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurological surgery in Galveston

Peter KanGalveston$276K
Koijan KainthThe Woodlands$1.3M
Luis DuarteSan Angelo$1.2M
Douglas FoxAustin$948K
Richard MeyratDallas$883K
Adam LewisCorpus Christi$792K
Arnold VardimanSan Antonio$687K
Andrew RoeserHouston$660K
Scott RobertsonRound Rock$606K
Sabatino BiancoArlington$564K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →